0001127602-21-009099.txt : 20210303 0001127602-21-009099.hdr.sgml : 20210303 20210303160516 ACCESSION NUMBER: 0001127602-21-009099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Perry Nicole D CENTRAL INDEX KEY: 0001657874 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 21708895 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-03-01 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001657874 Perry Nicole D C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Vice President - Accounting Common Stock 2021-03-01 4 M 0 2000 3.76 A 4347 D Common Stock 2021-03-01 4 S 0 2000 50.00 D 2347 D Stock Option (Right to Buy) 3.76 2021-03-01 4 M 0 2000 0 D 2025-07-31 Common Stock 2000 11161 D This is a scheduled exercise from a 10B5-1 trading plan. This option was granted on July 31, 2015 and is fully vested. /s/ David Watson, attorney-in-fact for Nicole Perry 2021-03-02